China Drug Maker’s Shares Soar On COVID-19 Vaccine Pact With AstraZeneca

Shares among leading China pharmaceutical makers have soared amid the COVID-19 pandemic.

Read the full post on Forbes - Healthcare

Russell Flannery, Forbes Staff